 |
|
|
 |
|
 |
|
|
|
|
|
|
|
OUR THERAPY
In 2002 we had a clinical breakthrough when we began
using increased doses of essential fatty acids and
phosphatidylcholine orally and intravenously. Patients
with Parkinson's Disease, Autism and Schizophrenia
had a profound improvement in their symptoms. In
the fall of 2003 we had an ALS patient in a wheelchair
who walked on the third day of our intravenous therapy
with phospholipids and glutathione. We have since
had patients with many different kinds of neurological
disorders who have responded to our therapy.
The PK IV Protocol TM and Detoxx TM Systems were
developed by Dr. Patricia Kane, Ph.D. for health care
professionals to have safe and efficient detoxification
methods via targeted supplementation and intravenous
therapy. By supporting membrane phospholipids,
methylation and sulfation which are crucial for positive
patient outcomes in toxicity states both cleansing and
nourishing of the tissues occurs at the same time.
Our approach to detoxification is from the cell membrane
prospective, with respect to essential fatty acid metabolism
and establishing cell membrane phospholipid stability.
Thus the health of the cell,the body and brain are stabilized.
The PK IV and oral protocols have been clinically effective in
reaching the systemic nature of neurotoxic and toxic syndromes
such as heavy metal burdens, microbial infections, toxic mold
exposure, chronic fatigue syndrome, Lyme, Fibromyalgia,
MS, IBS, Autism, Developmental Delay, Depression, ALS, Stroke, Environmental illness, mood disorders, Hypercoagulation, Parkinson's, Cardiovascular Disease
Hepatitis C and Longevity.
|
|
|
|
|
|
 |
|
 |
|
|
|
|
